# Combined Vaginal Misoprostol and Perivascular Vasopressin

> **NCT03815344** · PHASE4 · COMPLETED · sponsor: **Antonios Likourezos** · enrollment: 74 (actual)

## Conditions studied

- Leiomyoma
- Laparoscopy
- Uterine Myomectomy

## Interventions

- **DRUG:** Standard
- **DRUG:** Standard-vaginal misoprostol

## Key facts

- **NCT ID:** NCT03815344
- **Lead sponsor:** Antonios Likourezos
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-26
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03815344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03815344, "Combined Vaginal Misoprostol and Perivascular Vasopressin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03815344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*